Workshop on suramin with emphasis on prostate cancer: re-evaluation of response criteria.
van Rijswijk
R E
RE
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Cvitkovic
E
E
Wagstaff
J
J
Myers
C E
CE
D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D006801:Humans; D008297:Male; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013498:Suramin / Q000009:adverse effects / Q000627:therapeutic use*
D013498:Suramin; D017430:Prostate-Specific Antigen